Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.06 - $1.67 $309,944 - $488,308
292,400 Added 1405.77%
313,200 $363,000
Q4 2023

Feb 07, 2024

SELL
$1.26 - $1.79 $99,792 - $141,768
-79,200 Reduced 79.2%
20,800 $35,000
Q3 2023

Nov 07, 2023

BUY
$1.61 - $2.54 $96,992 - $153,019
60,244 Added 151.53%
100,000 $181,000
Q2 2023

Aug 07, 2023

SELL
$1.14 - $1.95 $168,290 - $287,864
-147,623 Reduced 78.78%
39,756 $73,000
Q1 2023

May 03, 2023

BUY
$1.2 - $2.19 $224,854 - $410,360
187,379 New
187,379 $249,000
Q3 2022

Nov 07, 2022

SELL
$0.73 - $3.74 $14,308 - $73,307
-19,601 Reduced 64.69%
10,699 $33,000
Q2 2022

Aug 09, 2022

BUY
$2.2 - $4.2 $66,660 - $127,260
30,300 New
30,300 $72,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.5B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.